科兴制药(688136.SH)：拟发行科技创新债券

Core Viewpoint - The company, Kexing Pharmaceutical (688136.SH), is responding to national policies on technological innovation by increasing its investment in R&D and optimizing its debt structure through the issuance of technology innovation bonds worth up to 800 million RMB [1] Group 1 - The company plans to apply for registration to issue technology innovation bonds in the interbank market [1] - The maximum amount of the bond issuance is set at 800 million RMB, including the principal amount [1] - This initiative aims to broaden financing channels and enhance the company's financial structure [1]